Čeština
|
Dansk
|
Deutsch
|
English
|
Español
|
Français
|
Italiano
|
Nederlands
|
Norsk
|
Polski
|
Português
|
Pусский
|
Suomi
|
Svenska
|
US
EHDN2016
ENFERMEDAD
GRUPO
REGISTRY
PROYECTOS
ENTRAR
Wet Biomarkers
-
Novedades
El proyecto
Centros
Austria
Bélgica
Coordinador
Asociaciones de Huntingto...
Antwerpen
Bierbeek
Bruselas - VUB
Bruselas - UCL
Bruxelles - ULB
Charleroi
Leuven
Liège (Luik)
República Checa
Dinamarca
Finlandia
Coordinador
Asociaciones de Huntingto...
Dates
Åland
Helsinki-HUH
Helsinki-Vaestoliitto
Kuopio
Oulu
Tampere
Turku-Suvituuli
Turku-TUH
Francia
Alemania
Ireland
Italia
Coordinador
Asociaciones de Huntingto...
Bari
Bologna
Brescia
Cagliari
Florencia
Génova
Milán
Nápoles
Pisa
Pozzilli
Roma
Roma-LIRH
Rome-Sant'Andrea
Países Bajos
Noruega
Polonia
Portugal
Rusia
España
Coordinación
Asociaciones de Huntingto...
Alicante-Alcoy
Badajoz
Barcelona - Bellvitge
Barcelona - Clinic i Provincia...
Barcelona - Mutua de Terra...
Barcelona - Santa Creu i Sa...
Barcelona - Merced
Bilbao
Burgos
Canaries
Granada
Fuenlabrada
Madrid-BTCIEN
Documents
Informed Consent
ERB
Madrid - Clínico
Madrid - FJD
Madrid - RyC
Murcia
Oviedo
Palma de Mallorca
Pamplona
Santiago
Sevilla-Macarena
Sevilla-HUVRocio
Sevilla-St-Ana
Valencia
Zaragoza
Suecia
Suiza
Reino Unido
Fuera de Europa
Grupos de trabajo
EH avanzada
Fenotipo conductual
Modificadores Biológicos
Acontecimientos
Reuniones
Reunión 2008/04
Reunión 2008/09
Reunión 2009
Biomarcadores
Banco de tejidos y cerebros...
Fenotipo cognitivo
Modificadores ambientales
Evaluación Funcional
Test y Consejo genético
Genes Modificadores
Acontecimientos
Reuniones
Reunión 2005/09
Reunión 2006/04
Reunión 2008/09
Reunión 2009/06
Meeting 2012/13
Economia de Salud
Pruebas de imagen
Huntington Juvenil
Fenotipo motor
Tratamiento Neuroprotector...
Fisioterapia
Acontecimientos
Reuniones
Reunión de mayo 2008
Reunión de sep 2008
Reunión de 2009
Meeting 2012
Meeting 2014
Meeting 2015
Meeting 2016
Call 2017 Subgroup Guide...
Calidad de vida
Cuidados del paciente
Tratamiento quirúrgico
Tratamiento Sintomático
Jóvenes
Acontecimientos
Reuniones
Meeting 2009/05
Meeting 2009/11
Meeting 2010/09
Miembros
Eventos
EHDN 2016
EHDN 2014
EHDN 2012
Introduction
Announcement
Programme Fri
Programme Sat
Programme Sun
Additional Meetings
Important Dates
Registration
Travel & Accommodation
EHA Registration
EHA Programme
Reception Dinner
About Stockholm
Abstract Submission
Reimbursement
Documents
Handouts
Presentations
Posters
Pathogenic mechanisms
Animal models
Choreatic disorders - no...
Genetic modifiers
Wet Biomarkers
Imaging
Clin characteristics
Clin char-motor
Clin char-cognitive
Clin char - behaviour
Clin char-other
Clinical studies
Genetic testing
Clinical care
Experimental Rx
Clinical Rx
Non-scientific
Contacts
Feedback & Evaluation
EHDN 2010
EHDN 2008
EHDN 2007
EHDN 2006
EHDN 2005
EHDN 2004
Comunicación
¿Cómo contactar?
Forums
Listas de correos
Publicación
Ofertas de trabajo
fecha
descripción
tamaño
autor
documento
03.08.26
Selisistat: potential pharmacodynamic readouts based on transcriptomics
32 kB
anonymous
f04-potential-pharmacodynamic-readouts
03.08.26
Mutant Huntingtin fragmentation in immune cells tracks Huntington’s Disease progression
32 kB
anonymous
f05-mutant-huntingtin-fragmentation
03.08.26
Whole blood SAGE digital gene expression profiling from Huntington's disease patients
32 kB
anonymous
f03-blood-sage-digital-gene-expression
03.08.26
Selisistat: Soluble htt protein levels as a potential pharmacodynamic readout
32 kB
anonymous
f02-soluble-htt-protein-levels
03.08.26
Establishment of novel assays for quantification of full-length wild-type and mutant Huntingtin by using the AlphaLISA technology
32 kB
anonymous
f01-establishment-novel-assays
03.08.26
A critical evaluation of inflammatory markers in Huntington’s Disease plasma
32 kB
anonymous
f06-critical-evaluation-inflammatory-m...
03.08.26
Cross-sectional and longitudinal associations between CRP and neuropsychiatric symptoms in HD
32 kB
anonymous
f07-crp-neuropsychiatric-symptoms
03.08.26
Abnormal regulation of macrophage-derived transforming growth factor – β 1 (TGF-β1) production in Huntington Disease
32 kB
anonymous
f12-abnormal-regulation-of-macrophage
03.08.26
8OHdG is not a biomarker for Huntington’s Disease; lessons for future biomarker studies
32 kB
anonymous
f14-8ohdg
03.08.26
Progredient deterioration of hepatic mitochondrial function in Huntington's Disease – measured by using the 13C-methionin breath test
32 kB
anonymous
f11-progredient-deterioration-hepatic-...
03.08.26
The study on molecular changes related to energy metabolism in Huntington’s disease subjects - looking for biomarkers
32 kB
anonymous
f09-molecular-changes-related-to-energ...
03.08.26
The autoimmune profile of Huntington`s Disease patients - a pilot study
32 kB
anonymous
f08-autoimmune-profile
03.08.26
A new biomarker in Huntington's disease
32 kB
anonymous
f15-new-biomarker
Esta carpeta contiene 13 documentos.
about us
|
privacy statement
|
disclaimer
|
terms of use